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Cells within the acidic extracellular environment of solid tumours maintain their intracellular pH (pHi) through the activity of
membrane-based ion exchange mechanisms including the Na
+/H
+ antiport and the Na
+-dependent Cl
7/HCO3
7 exchanger.
Inhibition of these regulatory mechanisms has been proposed as an approach to tumour therapy. Previously available inhibitors
of these exchangers were toxic (e.g. 4,4-diisothiocyanstilbene-2,2-disulphonic acid), and/or non-speciﬁc (e.g. 5-N-ethyl-N-
isopropyl amiloride). Using two human (MCF7, MDA-MB231) and one murine (EMT6) breast cancer cell lines, we evaluated
the inﬂuence of two new agents, cariporide (an inhibitor of the Na
+/H
+ antiport) and S3705 (an inhibitor of the Na
+-
dependent Cl
7/HCO3
7 exchanger) on the regulation of intracellular pH (pHi). The cytotoxicity of the two agents was
assessed by using clonogenic assays. Our results suggest that cariporide has similar efﬁcacy and potency to 5-N-ethyl-N-
isopropyl amiloride for inhibition of Na
+/H
+ exchange while S3705 is more potent and efﬁcient than 4,4-diisothiocyanstilbene-
2,2-disulphonic acid in inhibiting Na+-dependent Cl
7/HCO3
7 exchange. The agents inhibited the growth of tumour cells
when they were incubated at low pHe (7.0–6.8), but were non-toxic to cells grown at doses that inhibited the regulation of
pHi. Our results indicate that cariporide and S3705 are selective cytostatic agents under in vitro conditions that reﬂect the
slightly acidic microenvironment found in solid tumours.
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The microenvironment within many solid tumours is known to be
acidic (mean extracellular pH (pHe) % 6.9–7.0) as compared to
normal tissues (mean pHe % 7.4). The acidity in solid tumours is
due to the increased production of acidic metabolites such as lactic
acid and CO2 and to the limited ability of the tumour vasculature to
remove these acidic products of metabolism, which therefore accu-
mulate within the tumour microenvironment. Using a pH-sensitive
ﬂuorescent probe and ﬂuorescent microscopy applied to a solid
tumour growing in a transparent window, Helmlinger et al (1997)
demonstrated a gradual decrease of pHe from 7.4 to 6.7 as the
distance from blood vessels increased from 0 mM to 200 mM.
Under acidic conditions, cells regulate their pHi by buffering
protons that enter the cell, and by activating membrane-based
ion-exchange mechanisms, of which the most important are the
Na
+/H
+ antiport and the Na
+-dependent HCO3
7/Cl
7 exchanger.
While the intracellular buffering capacity serves to minimize the
change in pHi during minor inﬂux or efﬂux of H
+ or OH
7,
restoration of homeostasis is achieved by activating the membrane
based ion-exchange mechanisms (Murer et al, 1976; Thomas, 1977;
Tonnessen et al, 1990).
Na
+/H
+ antiports are expressed in all mammalian cells. Six
isoforms of the Na
+/H
+ antiports have been identiﬁed and named
NHE1–6 (Sardet et al, 1989; Orlowski et al, 1992; Tse et al,
1992; Tse et al, 1993; Wang et al, 1993; Klanke et al, 1995; Numata
et al, 1998). While NHE1 is found in most cells, NHE2-5 are tissue
speciﬁc and NHE6 is expressed in mitochondria (Counillon and
Pouyssegur, 2000). The ubiquitous pattern of expression of NHE1
suggests that it is the dominant form that cells use to regulate their
cell volume and pHi. When NHE1 is activated by intracellular
acidosis, it exports excess H
+ ions from the cytoplasm to the extra-
cellular environment in exchange for the intake of Na
+ ions with a
1:1 stoichiometry (Grinstein et al, 1984; Aronson, 1985).
The gene that encodes the Na
+-dependent HCO3
7/Cl
7 exchan-
ger was cloned and named NCBE (Wang et al, 2000). NCBE
regulates pHi by importing HCO3
7 from the extracellular space
into the cell to buffer excess protons, thus inhibiting changes in
pHi. The activity of NCBE depends on the presence of extracellular
Na
+ and HCO3
7, and on intracellular Cl
7 ions.
Our laboratory and others have evaluated previously the efﬁcacy
of available NHE-1 inhibitors, such as amiloride and its analogue
5-N-ethyl-N-isopropyl amiloride (EIPA) with the goal of assessing
their possible role in the treatment of solid tumours, where they
might contribute to cellular toxicity under acidic conditions. These
agents are quite effective inhibitors of Na
+/H
+ exchange but lack
speciﬁcity (Kleyman and Cragoe, 1988; Newell et al, 1992; Horvat
et al, 1993; Murata et al, 1995). Despite their lack of speciﬁcity,
experimental studies using amiloride and EIPA have suggested that
inhibition of NHE-1 might be beneﬁcial to patients with myocar-
dial ischemia (Pierce et al, 1993; Baumgarth et al, 1996). A new
inhibitor, cariporide (HOE642) has been developed to inhibit
speciﬁcally the NHE-1 isoform (Scholz et al, 1995) by competing
with Na
+ for its binding site. Phase II/III clinical trials of cariporide
have been completed and suggest that this agent provides patients
E
x
p
e
r
i
m
e
n
t
a
l
T
h
e
r
a
p
e
u
t
i
c
s
Received 1 February 2002; revised 26 April 2002; accepted 26 April 2002
*Correspondence: Dr I Tannock; E-mail: ian.tannock@uhn.on.ca
British Journal of Cancer (2002) 87, 238–245
ã 2002 Cancer Research UK All rights reserved 0007–0920/02 $25.00
www.bjcancer.comwith protection from cardiac ischemia and reperfusion injury
(Karmazyn, 2000; Theroux et al, 2000).
Previously, inhibitors of Na
+-dependent Cl
7/HCO3
7 exchange
were limited to stilbene derivatives such as 4,4-diisothiocyanstil-
bene-2, 2-disulphonic acid (DIDS). This agent provides partial
non-reversible inhibition of the exchanger and is toxic to cells in
vitro at 0.4 mM and quite toxic in vivo (Yamagata and Tannock,
1996). More recently, investigators from the Aventis Pharmaceuti-
cal Company have developed a new inhibitor of the Na
+-dependent
Cl
7/HCO3
7 exchanger, known as S3705 (unpublished data).
Under acidic conditions, proliferation of cells is known to be
dependent on the pH regulatory mechanisms to maintain their
intracellular pH within the range of pHi 7.2-7.4 (Rotin et al,
1989). If NHE-1 and NCBE are inhibited, the pHi of cells might
be expected to establish equilibrium with the extracellular pH
(pHe), which would inhibit selectively the metabolism and growth
of tumour cells that are in an acidic microenvironment (Bock and
Frieden, 1976; Busa and Nuccitelli 1984; Musgrove et al, 1987).
Therefore, cariporide and S3705 might have cytostatic effects on
cells growing under the acidic conditions that are found in solid
tumours although this will depend on the ability of these agents
to penetrate tissue to reach these acidic cells. Cells in these regions
may be relatively resistant to chemotherapy due to poor drug
access, and agents that inhibit the proliferation of cells in acidic
regions of tumours might have therapeutic value when used in
conjunction with chemotherapy.
In the present article, we characterise the activity of cariporide
and S3705 as inhibitors of their respective exchangers, the Na
+/
H
+ antiport and the Na
+-dependent Cl
7/HCO3
7 exchanger, in
cultured malignant cells. We measure the pHi and the rate of
pHi recovery after intra-cellular acidiﬁcation. Finally, we assess
the ability of these agents to inhibit cell proliferation and to cause
cell death, as a function of pHe.
METHODS
Cells
Experiments were performed using murine EMT-6 cells derived
from a mammary sarcoma, and two human breast cancer cell lines,
MCF7 and MDA-MB231 (both purchased from the American Type
Culture Collection). Cells were maintained in a-Minimum Essen-
tial Medium (a-MEM) with 10% foetal bovine serum (FBS). The
cells were checked periodically to ensure absence of Mycoplasma
by staining the cells with Hoescht 33258. New cultures were re-
established from frozen stock every 3 months. In experiments
where cells were grown at different pHe, the cells were maintained
in pH-adjusted media. pH-adjusted medium was prepared by
mixing a-MEM with 10% FBS, 25 mM HEPES, and the appropriate
amount of HCl or NaOH. The medium was allowed to equilibrate
in 95% air and 5% CO2 and its pH was repetitively re-adjusted
during a one week period.
Reagents
Cariporide, S3705 and rat-chow containing 0.6% cariporide were
supplied by Aventis (Frankfurt, Germany). 5-N-ethyl-N-isopropyl
amiloride (EIPA) was obtained from Aldrich (Milwaukee, WI,
USA). DIDS, Nigericin and melphalan were purchased from Sigma
(Oakville, ON, Canada). 2'7'-bis-(2-caboxyethyl)-5-(and-6)carbox-
yﬂuorescein (BCECF) acetoxymethyl ester was purchased from
Molecular Probes (Eugene, OR, USA).
Solutions
Cariporide and S3705 were dissolved in phosphate buffered saline.
EIPA was dissolved in 10% DMSO and DIDS was dissolved in
distilled water.
Unless otherwise indicated, all solutions were HCO3
7 free. Solu-
tion A contained 140 mM NaCl, 5 mM KCl, 5 mM glucose, 1 mM
CaCl2,1m M MgCl2, buffered to pH 7.4 with 20 mM MES/Tris.
NaHCO3 solution contained 25 mM NaHCO3, 115 mM NaCl,
and other components identical to those in the Solution A; it
was prepared and stored without NaHCO3, which was added
immediately before use. N-Methyl-D-glucamine (NMG) solution
was prepared as an iso-osmotic replacement of NaCl; the other
components were identical to those described above for Solution
A. NH4Cl solution contained 15 mM NH4Cl and other components
identical to the NMG solution. KCl solution contained 20 mM
NaCl and 140 mM K
+ ions.
Evaluation of pHi and its regulation in cells grown in
monolayer
Cells grown as a monolayer on a glass coverslip were exposed to
2 mgm l
71 of the acetoxymethyl ester BCECF in serum free a-
MEM at 378C for 30 min. The coverslip was rinsed with PBS
and placed into a cuvette using a specially designed holder aligned
at an angle of 308 to the excitation beam of a SLM Aminco
Bowman Series 2 ﬂuorescence spectrometer. The holder also served
as a cap for the cuvette, minimizing the loss of CO2. The cells were
exposed to excitation beams at 495 nM and 440 nM. The ratio of
the ﬂuorescence emitted at 525 nM when excited by the 495 nM
beam (pH dependent emission) to that emitted at 525 nM when
excited by the 440 nM beam (pH independent emission) was used
to calculate pHi. A calibration curve of the ﬂuorescence ratio
against pHi was made by placing a coverslip into cuvettes contain-
ing nigericin and KCl solution of various pHe (7.4–6.2) (Thomas
et al, 1979).
The ammonium prepulse method was used to achieve intracel-
lular acidiﬁcation. The cells were placed in 15 mM NH4Cl for
30 min. Intracellular acidiﬁcation was produced when the cells
were transferred to NMG solution free of NaCl and NH4Cl (Boron,
1989).
Following acidiﬁcation, the NMG solution was replaced with
Solution A (containing 140 mM NaCl), and the consequent rate
of increase in pHi was used to measure the activity of the Na
+/
H
+ exchanger. The efﬁcacy of cariporide and EIPA in inhibiting
this exchanger was evaluated by quantitating Na
+/H
+ exchange in
the presence of different concentrations of inhibitors. Similarly,
the activity of the Na
+-dependent Cl
7/HCO3
7 exchanger was
assessed by replacing the NMG solution with NaHCO3 solution
containing 10 mM of EIPA (to inhibit the Na
+/H
+antiport). S3705
and/or DIDS were added at different concentrations to compare
their inhibitory effects on the exchanger. The combined activity
of the pH regulatory mechanisms was measured by replacing the
NMG solution with NaHCO3 solution. Measurements of change
in pHi under various conditions were converted to estimates of
H
+ efﬂux by using the calculations presented previously (Boron,
1989).
To evaluate possible changes in expression of the exchangers
induced by exposure to their inhibitors, cells were grown in the
presence or absence of 80 mM cariporide and 40 mM S3705 at differ-
ent pHe for up to 7 days then seeded on coverslips and allowed to
attach overnight before use. The pHi of the cells, and activity of the
exchangers was then evaluated as described above.
Assays of in vitro toxicity
The toxicity of cariporide and/or S3705 to cells grown under
conditions of different pHe was evaluated by a clonogenic assay.
Cells in monolayer were exposed to cariporide (80 mM) and/or
S3705 (40 mM)i na-MEM + 10% FBS + 25 mM HEPES buffered
to various pHe (7.4–5.9). Control cells were exposed to the
solvents used for cariporide and S3705. Following a 24 h incuba-
tion period at 378C in 95% air and 5% CO2, the cells were
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were incubated for 10–14 days and the colonies were stained with
methylene blue. Colonies containing at least 50 cells were counted
and the surviving fraction was calculated as the ratio of the plating
efﬁciencies of treated and control plates exposed to the same pHe.
Inhibition of cell proliferation
Cells were seeded into 25 cm
2 ﬂask and left overnight in a-MEM.
Following the overnight incubation, the medium was replaced
with medium adjusted to different pH with or without 80 mM
cariporide and 40 mM S3705. The pH-adjusted media was changed
every 2 days until the end of the 7-day experiment. At 2-day
intervals, one ﬂask was selected at random, the cells were detached
with 0.1% trypsin, and counted. Growth curves were plotted as a
function of pHe in the presence or absence of cariporide and
S3705.
RESULTS
Ability of cariporide and S3705 to inhibit their respective
pHi regulatory mechanisms
We assessed the ability of cariporide to inhibit the activity of the
Na
+/H
+ antiport by measuring H
+ efﬂux from cells following intra-
cellular acidiﬁcation using the ammonium-prepulse method. Our
results indicate that cariporide has similar efﬁcacy and potency
as EIPA over the range of concentrations that were tested on the
MCF7 and EMT6 cell lines (Figure 1). The efﬁcacy of cariporide
to inhibit the Na
+/H
+ antiport of MDA-MB231 cells was tested
only at a concentration of 5 mM. At a concentration of 5 mM,
cariporide was able to inhibit up to 90% of the activity of the Na
+/
H
+ antiport in each cell line. The experiments were repeated in the
presence of 10% FBS, and there was no signiﬁcant effect of serum
on the inhibitory effects of cariporide (data not shown).
Similarly, we compared the efﬁcacy and potency of S3705 and
DIDS to inhibit the activity of the Na
+-dependent Cl
7/HCO3
7
exchanger. In the absence of 10% FBS, S3705 was more effective
and more potent than DIDS (Figure 2). In all three cell lines, up
to 80% of exchanger activity was inhibited by 40 mM S3705 (the
efﬁcacy of S3705 to inhibit the Na
+-dependent Cl
7/HCO3
7
exchanger in MDA-MB231 cells was evaluated only at 40 mM
S3705). However, in the presence of 10% FBS, higher concentra-
tions of S3705 were required to obtain equivalent inhibitory
effects although this agent was still more effective and more potent
than DIDS (Figure 3).
The contributions of each of the regulatory mechanisms to the
recovery of pHi following acidiﬁcation, and the maximum inhibi-
tory effects from different agents are summarised in Table 1.
Effects of cariporide and S3705 on the regulation of
intracellular pH
We measured the pHi of MCF7 and MDA-MB231 cells after they
were incubated for either 24 h or 7 days at pHe 7.4 or 6.8, with
or without cariporide and S3705 to evaluate changes in pHi (Figure
4) and proton efﬂux rate (Figure 5). Our results indicate that both
cell lines maintained pHi at physiological levels (pHi % 7.3–7.4)
when they were incubated for 24 h at pHe 7.4 or 6.8 in the absence
of the agents. Incubation in cariporide and S3705 at either pHe
caused the pHi of the cells to drop and this decrease in pHi was
more marked following incubation at pHe 6.8.
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Figure 1 Comparison of the inhibitory effects of EIPA and cariporide on
the activity of the Na
+/H
+ antiport (measured by the H
+ efﬂux rate in mM
s
71) for (A) MCF7 and (B) EMT6 cells. The results indicated are the
mean+s.e.m. of at least three experiments.
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Figure 2 Comparison of the inhibitory effects of DIDS and S3705 on the
activity of the Na
+ dependent Cl
7/ HCO3
7 exchanger (measured by H
+
efﬂux rate in mM s
71) for (A) MCF7 and (B) EMT6 cells. Experiments were
performed in the absence of serum. The results indicated are the mean+
s.e.m. of at least three experiments.
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or 6.8, we observed that the proton efﬂux rates of MCF7 cells
increased slightly in comparison with cells incubated at the same
levels of pHe in the absence of the inhibitors (Figure 5). Cells
maintained in the absence of the inhibitors at pHe 7.4 and 6.8
maintained the same proton efﬂux rates. Despite the upregulated
proton efﬂux rates, cariporide and S3705 maintained their activity
to inhibit the exchangers in the cells (Figure 5).
Toxicity of cariporide and S3705 to cultured cells
The results of clonogenic assays indicate that neither compound
was toxic to MCF7 or MDA-MB231 cell lines when cariporide
(80 mM) and S3705 (40 mM) were added individually or together
to cells buffered to pHe in the range of 7.4–5.9 (data not shown).
Inhibition of tumour cell proliferation by cariporide and
S3705
The ability of S3705 and cariporide to inhibit the proliferation of
MDA-MB231 and MCF7 cells was assessed by evaluating the
growth rate of cells at different pHe in the presence or absence
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Figure 3 Comparison of the inhibitory effects of DIDS and S3705 in the
presence of 10% foetal bovine serum (FBS) on the activity of the Na
+ de-
pendent Cl
7/ HCO3
7 exchanger (measured by H
+ efﬂux rate in mM s
71)
for (A) MCF7 and (B) EMT6 cells. The results indicated are the mean+
s.e.m. of at least three experiments.
Table 1 Hydrogen ion efﬂux rate (mM s
71) following intracellular acidiﬁcation of EMT6, MCF7 and MDA-MB231
cells. Figures in parentheses represent the percentage of residual activity as compared to the total hydrogen ion efflux
rate when both exchangers are active. Mean+s.e.m. of at least three experiments
Test solution Exchanger evaluated EMT6 MCF7 MDA-MB231
NaHCO3 solution NHE and NCBE 868+99 748+122 385+71
(100%) (100%) (100%)
Solution A (NaCl) NHE 460+5 468+52 244+27
NCBE (inactive) (53%) (63%) (63%)
NaHCO3 solution+ NCBE 466+19 245+15 131+35
10 mM EIPA NHE inhibited (54%) (33%) (34%)
Solution A+ NHE inhibited 64+93 7 +31 8 +3
10 mM EIPA NCBE (inactive) (7%) (5%) (5%)
Solution A+10 mM NHE inhibited 68+14 40+17 43+0.1
Cariporide NCBE (inactive) (8%) (5%) (11%)
NaHCO3 solution+10 mM EIPA+ NHE inhibited 79+15 98+11 73+12
100 mM DIDS NCBE inhibited (9%) (13%) (19%)
NaHCO3 solution+10 mM EIPA+ NHE inhibited 122+12 47+64 6 +5
40 mM S3705 NCBE inhibited (14%) (6.3%) (12%)
NaHCO3 solution+10 mM NHE inhibited 38+10 52+14 20+8
Cariporide+40 mM S3705 NCBE inhibited (4%) (7%) (5%)
For experiments using MDA-MB231 cells, 5 mM cariporide was used instead of 10 mM; NHE–Na
+/H
+ antiport; NCBE–Na
+-dependent
Cl
7/HCO3
7 exchanger.
p
H
i
7.6
7.4
7.2
7
6.8
6.6
7.4 7.4sc 6.8 6.8sc
Environment of incubation
MCF7      MDA-MB231
Figure 4 Intracellular pH (pHi) of MCF7 cells (light histograms) and
MDA-MB231 cells (dark histograms) following a 24-h incubation period
in media adjusted to different pHe (7.4 or 6.8) in the absence or presence
of S3705 and cariporide (SC). The results indicated are the mean+s.e.m.
of at least three experiments. Student t-test indicates that the pHi of the
cells incubated in the presence of the inhibitors is lower than the pHi of
cells incubated at the same pHe in their absence (i.e. 7.4 vs 7.4SC, 6.8 vs
6.8SC) (P40.02, both comparisons).
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decreased growth rates. The growth rates of the cells at pHe 7.4
and 7.2 in the presence of 5 mM S3705 and 10 mM cariporide were
not signiﬁcantly different from the growth rates of the control cells
grown in the same pHe. However, MDA-MB231 cells that were
incubated with 5 mM S3705 and 10 mM cariporide at pHe 7.0 or
6.8 had a slower rate of growth than control cells at the same
pHe (data not shown). In contrast, the growth rates of MCF7 cells
at pHe 7.0 or 6.8 in the presence of 5 mM S3705 and 10 mM
cariporide did not differ from untreated MCF7 cells grown at
pHe 7.0 or 6.8. When these experiments were repeated using higher
concentrations of S3705 (40 mM) and cariporide (80 mM), the inhi-
bitory effects of the agents were similar for MDA-MB231 cells
(Figure 6A), while MCF7 grown at pHe 7.0 or 6.8 were also inhib-
ited from proliferating as compared to control cells growing in the
same pHe (Figure 6B).
DISCUSSION
Our group and others have tried previously to exploit the acidic
microenvironment in solid tumours as a treatment for cancer
(Horvat et al, 1993; Newell and Tannock, 1989). Although these
prior studies showed that inhibiting the regulation of pHi and
inducing intracellular acidosis could cause tumour cell death, the
therapeutic potential of these strategies was limited by toxicity or
by lack of speciﬁcity of the agents used.
The present study demonstrates the inhibitory effects of caripor-
ide and S3705 on the Na
+/H
+ antiport and the Na
+-dependent
Cl
7/HCO3
7 exchanger of three malignant cell lines, two of them
derived from human breast cancers. Our results suggest that
cariporide is as potent and efﬁcient as EIPA while S3705 is more
efﬁcient and potent than DIDS. Data from Aventis Pharmaceutical
company suggest that a large proportion of S3705 is plasma bound
and our results conﬁrm that a higher concentration of S3705 is
needed to inhibit Na
+-dependent Cl
7/HCO3
7 exchange in the
presence of serum. However, S3705 is more effective and potent
than DIDS, either in the presence or absence of serum.
Following mild acidiﬁcation of the cell lines that were tested,
Table 1 shows that regulation of pHi was due largely to the
combined activity of the Na
+/H
+ antiport and the Na
+-dependent
Cl
7/HCO3
7 exchanger. Combined application of cariporide and
S3705 abolished all but 4–7% of the rate of H
+ efﬂux in these
cells. Residual H
+ efﬂux might be due to incomplete inhibition
of the exchangers, or to the activity of other pH regulatory
mechanisms including other isoforms of HCO3
7/Cl
7 or Na
+/H
+
exchangers, H
+-ATPases and the transport of H
+ from the cyto-
plasm into endosomal vesicles.
It is known that the extracellular pH in solid tumours is more
acidic (mean values of pHe % 6.9–7.0) than in normal tissues
(mean value of pHe % 7.4), and that the pHe in tumours
decreases with increasing distance from blood vessels (Helmlinger
et al, 1997; Wike-Hooley et al, 1984; Vaupel et al, 1989). Although
there may be a small increase in the number of apoptotic cells in
regions of low pH, cells have a remarkable ability to withstand
extracellular acidity when evaluated by clonogenic assay. Both
cariporide (80 mM) and S3705 (40 mM) failed to show toxicity to
cells grown in monolayers at doses that inhibited pHi regulation,
even at relatively low levels of extracellular pH. This is consistent
with previous results for EIPA and DIDS which only become toxic
at low pHe if the cells are ﬁrst acidiﬁed by using an ionophore
such as nigericin (Newell et al, 1992; Yamagata and Tannock,
1996). Thus cariporide and S3705 are unlikely to be directly toxic
to cells in solid tumours, despite the tendency of the microenviron-
ment to be acidic; they might however enhance the activity of
agents that cause intracellular acidiﬁcation (Newell et al, 1992;
Yamagata and Tannock, 1996), but this was not evaluated directly.
It has been shown that intracellular acidosis can inhibit cellular
metabolism: low pHi may interfere with the folding and function
of proteins such as DNA polymerase and phospho-fructokinase
(Bock and Frieden, 1976; Busa and Nuccitelli, 1984). Low pHi,
in addition to inhibiting the glycolytic pathway can increase
consumption of ATP as the cell activates its H
+ ATPase to export
H
+ to the extracellular environment or into acidic vesicles. Some
investigators have reported that intracellular acidosis could also
lead to the activation of the apoptotic cascade (Shrode et al,
1997; Park et al, 1999; Matsuyama et al, 2000), while others have
shown that low pHi causes cells to accumulate in G1 phase
(Musgrove et al, 1987).
To verify the ability of cariporide and S3705 to change the pHi
of cells cultured in vitro and thus lead to decreased cellular prolif-
eration, we incubated the cells for 24 h at pHe 7.4 and 6.8 in the
presence or absence of the agents. Following the incubation period,
we observed that cells in media adjusted to pHe 7.4 or 6.8 without
the agents maintained a higher pHi than the cells that were incu-
bated at the same pHe with the agents present. This may be due to
the accumulation of H
+ ions that cannot be excreted in the
presence of cariporide and S3705. We then tested the ability of
cariporide and S3705 to maintain their inhibitory effects on the
membrane-based exchange mechanisms. MCF7 cells were incu-
bated for 7 days in media adjusted to different pHe in the
presence or absence of the inhibitors. We found that cells grown
at pHe 7.4 showed similar H
+ efﬂux rates as cells grown at pHe
6.8. Cells incubated for 7 days with cariporide and S3705 showed
up-regulated H
+ efﬂux rates at both pHe 7.4 and 6.8. The cells
were given ample time (3–4 h) to restore their pHi prior to testing
their H
+ efﬂux rates, thus the increase H
+ efﬂux rates are probably
not due to increased H
+ gradients in cells treated with cariporide
and S3705. However, when we measured the H
+ efﬂux rate in
the presence of cariporide and S3705, we found that the agents still
provided almost complete inhibition of the exchangers. These
results demonstrate the ability of the inhibitors to maintain inhibi-
tion of the regulation of pHi, which might lead to the selective
inhibition of proliferation of cells growing in acidic conditions.
When we incubated the cells at different pHe (7.4–6.8) in the
presence or absence of 10 mM cariporide and 5 mM S3705, concen-
trations that would effectively inhibit the exchangers, we found that
the inhibitors had minimal effects on the growth rate of cells at
physiological pHe (7.4 and 7.2). However, the presence of caripor-
ide and S3705 in media adjusted to pHe 7.0 and 6.8 decreased the
rate of growth of the cells. Higher concentrations of these agents
were needed to inhibit the growth rate of MCF7 cells. These effects
might be useful in inhibiting the tumour proliferation of tumour
cells that are situated in slightly acidic regions of tumours.
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Figure 5 Light histograms: Comparison of the maximum H
+ efﬂux rates
(measured in mM s
71) of MCF7 cells after incubation for 7 days in media
adjusted to different pHe (7.4 or 6.8) in the absence or presence of
S3705 and cariporide (SC). The agents were not present during evaluation
of H
+ efﬂux. Dark histograms: Evaluation of H
+ efﬂux in the presence of
S3705 and cariporide following similar incubation. The results indicated
are the mean+s.e.m. of at least three experiments. Student t-test indicates
that there was a signiﬁcant difference in the H+ efﬂux rates of cells incu-
bated at pHe 7.4 vs 7.4SC (P40.05) and a non-signiﬁcant trend
(P40.10) is observed at pHe 6.8.
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tion than more proximal cells, (e.g Hirst et al, 1982), proliferation
of cells from such regions is probably responsible for re-growth of
many solid tumours following treatment with radiation or with
anti-cancer drugs.
Tumour repopulation, or the proliferation between dose frac-
tions of cells that survive the cytotoxic effects of radiotherapy, is
recognized as a probable cause of treatment failure (Withers et
al, 1988; Maciejewski et al, 1989). There is evidence to suggest that
following fractionated irradiation applied to murine and human
tumours, the repopulation rate of the tumours accelerates with
time (Withers et al, 1988; Begg et al, 1991; Milas et al, 1991;
Durand, 1997). This accelerated repopulation may be due to an
increased growth fraction (Sham and Durand, 1999), to reduced
cell loss or to down-regulation of apoptosis (Thames et al, 1996).
Due to accelerated repopulation, higher doses of radiation or accel-
erated radiotherapy (or radiation given over shorter total time)
may be required to achieve tumour control (Withers et al, 1988;
Maciejewski et al, 1989).
Unlike radiotherapy, where dose fractions are usually given to
the patient once a day, patients undergoing chemotherapy most
often receive courses of treatment at less frequent intervals, typi-
cally every three weeks. This is necessary to allow recovery (by
repopulation) of critical normal tissues such as the bone marrow.
Repopulation of tumour cells during the longer intervals between
courses of chemotherapy is likely to be an important factor that
undermines the efﬁcacy of treatment (Milas et al, 1991; Davis
and Tannock, 2000).
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Figure 6 Comparison of the growth rate of (A) MDA-MB231and (B) MCF7 cells in media adjusted to different pHe (7.4–6.8) in the absence (solid lines)
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selective cytostatic agents given during radiotherapy or between
courses of chemotherapy has substantial potential to increase their
therapeutic efﬁcacy. Since repopulation of normal tissues is neces-
sary for their recovery, methods to inhibit repopulation must be
tumour speciﬁc. Radiation will kill selectively aerobic cells in
tumours that are likely to be at higher pH while anticancer drugs
are also likely to exert preferential cell kill against cells that are
close to tumour blood vessels because of higher rates of cell prolif-
eration and/or limited tissue penetration of anti-cancer drugs
(Tunggal et al, 1999; Tannock et al, 2002). Thus agents such as
cariporide and S3705 might decrease the rate of cellular prolifera-
tion of cells in acidic environments that survive such treatments.
Experiments to test the potential of S3705 and cariporide to inhibit
repopulation in experimental tumours between cycles of
chemotherapy are in progress. These agents have been shown to
exert in vivo effects to limit myocardial ischaemia; a key question
is whether sufﬁcient concentration may be achieved in vivo to inhi-
bit the proliferation of cancer cells under the acidic conditions
found in solid tumours.
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